Journal article · 2020 · Open access

Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability

Sumeet U. Nayak, Jennifer A. Calvo, Ke Cong, Min Peng, Emily A. Berthiaume, Jessica Jackson, Angela M. Zaino, Alessandro Vindigni, Matthew Kyle Hadden, Sharon B. Cantor

Science Advances, 6(24), eaaz7808 · Published 10 June 2020 · DOI 10.1126/sciadv.aaz7808

Open PDFView at the publisherCite this paper

In brief

“Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability” is a 2020 journal article by Sumeet U. Nayak and 9 co-authors, published in Science Advances. OpenAlex counts 123 citations as of 21 November 2026, which puts it in the top 1% of works published in 2020 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Science Advances.

Citations
123
Most cited in
2021 (27)
Field-weighted impact
4.55
References
76
Authors
10

Abstract

The replication stress response, which serves as an anticancer barrier, is activated not only by DNA damage and replication obstacles but also oncogenes, thus obscuring how cancer evolves. Here, we identify that oncogene expression, similar to other replication stress-inducing agents, induces single-stranded DNA (ssDNA) gaps that reduce cell fitness. DNA fiber analysis and electron microscopy reveal that activation of translesion synthesis (TLS) polymerases restricts replication fork slowing, reversal, and fork degradation without inducing replication gaps despite the continuation of replication during stress. Consistent with gap suppression (GS) being fundamental to cancer, we demonstrate that a small-molecule inhibitor targeting the TLS factor REV1 not only disrupts DNA replication and cancer cell fitness but also synergizes with gap-inducing therapies such as inhibitors of ATR or Wee1. Our work illuminates that GS during replication is critical for cancer cell fitness and therefore a targetable vulnerability.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Nayak, S. U., Calvo, J. A., Cong, K., Peng, M., Berthiaume, E. A., Jackson, J., Zaino, A. M., Vindigni, A., Hadden, M. K., & Cantor, S. B. (2020). Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability. Science Advances, 6(24), eaaz7808. https://doi.org/10.1126/sciadv.aaz7808

MLA 9

Nayak, Sumeet U., et al. “Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability.” Science Advances, vol. 6, no. 24, 2020, p. eaaz7808. https://doi.org/10.1126/sciadv.aaz7808.

Chicago

Nayak, Sumeet U., Jennifer A. Calvo, Ke Cong, Min Peng, Emily A. Berthiaume, Jessica Jackson, Angela M. Zaino, Alessandro Vindigni, Matthew Kyle Hadden, and Sharon B. Cantor. 2020. “Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability.” Science Advances 6 (24): eaaz7808. https://doi.org/10.1126/sciadv.aaz7808.

Harvard

Nayak, S. U. et al. (2020) ‘Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability’, Science Advances, 6(24), p. eaaz7808. doi:10.1126/sciadv.aaz7808.

IEEE

S. U. Nayak et al., “Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability,” Science Advances, vol. 6, no. 24, p. eaaz7808, 2020, doi: 10.1126/sciadv.aaz7808.

BibTeX

@article{nayak2020inhibition,
  title     = {{Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability}},
  author    = {Nayak, Sumeet U. and Calvo, Jennifer A. and Cong, Ke and Peng, Min and Berthiaume, Emily A. and Jackson, Jessica and Zaino, Angela M. and Vindigni, Alessandro and Hadden, Matthew Kyle and Cantor, Sharon B.},
  journal   = {Science Advances},
  year      = {2020},
  volume    = {6},
  number    = {24},
  pages     = {eaaz7808},
  doi       = {10.1126/sciadv.aaz7808},
  url       = {https://doi.org/10.1126/sciadv.aaz7808}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202088
20212727
20221616
20231919
20242222
20251616
20261515

Its field-weighted citation impact is 4.55: it has been cited 4.55 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms

  • translesion synthesis
  • Rev1
  • replication stress response
  • single-stranded DNA
  • replication fork reversal
  • small molecule inhibitors
  • ATR inhibitors
  • WEE1 inhibitor

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Nayak, S. U., Calvo, J. A., Cong, K., Peng, M., Berthiaume, E. A., Jackson, J., Zaino, A. M., Vindigni, A., Hadden, M. K., & Cantor, S. B. (2020). Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability. Science Advances, 6(24), eaaz7808. https://doi.org/10.1126/sciadv.aaz7808

How many times has this paper been cited?

123 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Science Advances: sign in and open the PDF from this page.

Who wrote this paper?

Sumeet U. Nayak, Jennifer A. Calvo, Ke Cong, Min Peng, Emily A. Berthiaume, Jessica Jackson, Angela M. Zaino, Alessandro Vindigni, Matthew Kyle Hadden, Sharon B. Cantor.

What is the DOI of this paper?

10.1126/sciadv.aaz7808, permanently at https://doi.org/10.1126/sciadv.aaz7808. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.